id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-D-0033-0003,FDA,FDA-2003-D-0033,Guidance for Industry and Food and Drug Administration Staff: Food and Drug Administration and Industry Actions on Premarket Notification Submissions: Effect on Food and Drug Administration Review Clock and Performance Assessment,Other,Guidance,2004-05-25T04:00:00Z,2004,5,,,2012-11-20T14:37:29Z,,0,0,090000648048162a
FDA-2003-D-0033-0002,FDA,FDA-2003-D-0033,See FDA-2003-D-0033-0003,Supporting & Related Material,GDL-Guidance,2004-05-25T04:00:00Z,2004,5,,,2012-11-20T14:39:28Z,,0,0,0900006480481629
FDA-2003-D-0033-0001,FDA,FDA-2003-D-0033,Guidance for Industry and Food and Drug Administration Staff: Food and Drug Administration and Industry Actions on Premarket Notification Submissions: Effect on Food and Drug Administration Review Clock and Performance Assessment; Availability,Notice,Notice of Availability,2004-05-24T04:00:00Z,2004,5,2004-05-21T04:00:00Z,2005-05-24T03:59:59Z,2013-06-25T01:36:10Z,,0,0,0900006480481625